inflammatory bowel disease, institute of cancer research

Groundbreaking Bowel Cancer Test Is 90 Percent Accurate At Predicting Disease In Those At High Risk
Scientists say a groundbreaking new test can predict patients at high risk of developing bowel cancer with 90 per cent accuracy. The study, published in the journal Gut, could lead to blood testing for those with irritable bowel diseases like ulcerative colitis or Crohn’s who were most at risk of developing bowel cancer and help avoid some invasive procedures.
New bowel cancer test has ‘90% accuracy’ at predicting disease in those at high risk – without invasive procedures
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop the disease, research has shown. People with inflammatory bowel
Bowel cancer prediction test for IBD patients 90% accurate
A new method for detecting bowel cancer is more than 90% accurate at predicting which higher-risk people will develop the disease, according to research. About 500,000 people in the UK live with inflammatory bowel disease (IBD), including Crohn's and ulcerative colitis.
New colorectal cancer prediction test is more than 90% accurate
A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as colorectal cancer, in the five years.
Cancer breakthrough as new test has 90% accuracy predicting who is high risk
Cancer Research UK says the new approach should mean fewer people with inflammatory bowel disease will need to undergo surgery or regular colonoscopies.
New bowel cancer detection method more than 90% accurate, research finds
The study, funded by Cancer Research UK, could lead to a blood test which will inform doctors which inflammatory bowel disease patients are most at risk of cancer.
Rolling Out18h
Ulcerative colitis and its impact on daily life
Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...
Ibj.com2d
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Genetic risk factor for Crohn's disease influences natural microbiome changes during pregnancy, mouse study finds
Pregnancy is accompanied by profound changes in the body. Among other things, these affect the energy metabolism and the ...
Wearable devices like Fitbit can predict IBD flares 7 weeks in advance
Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...
Medscape3d
Women Researchers Remain Underrepresented in Pharma-Sponsored IBD Presentations
Study urges industry to be more transparent and fairer in selecting speakers, and to recruit more women to steering ...
pharmaphorum20h
3rd Precision Medicine in Inflammatory Bowel Disease Summit | May 13-15, 2025
Featuring three days of data-driven sessions from 25+ world-class speakers, the 3rd Precision Medicine in Inflammatory Bowel Disease returns as the field’s most comprehensive learning and networking ...
Waterlooville man who lost his wife to bowel cancer welcomes research breakthrough
A Waterlooville father who lost his wife to bowel cancer after living with colitis for more than half her life, has welcomed ...
Bowel cancer breakthrough as game-changing test could detect who will develope disease
The groundbreaking study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in ...